• Implications of GERD phenotypes
• Key new concepts in Barrett’s esophagus
• Optimal management strategies for EoE
• Clinical significance of the Chicago classification 4.0

Rena Yadlapati, MD
Prasad Iyer, MD, AGAF
Nirmala Gonsalves, MD, AGAF
C. Prakash Gyawali, MD, MRCP

• Eosinophilic GI diseases – More than meets the eye
• Novel concepts in functional dyspepsia
• New paradigms in H. pylori treatment in 2022
• PPI safety concerns – enough already?

Kathryn Peterson, MD
Nicholas J. Talley, MD, PhD, AGAF
Steven Moss, MD, MBBS, AGAF
Paul Moayyedi, MD, PhD, AGAF

• Pancreatic cysts – Survey, ablate or leave alone
• Best practices for management of acute pancreatitis
• Role of EUS – Guided gallbladder drainage in acute cholecystitis
• Current role of gastroenterologist in management of obesity

Anne Marie Lennon, MD, PhD, AGAF
Vikesh Singh, MD, MSc
Shayan S. Irani, MD
Andres Acosta, MD, PhD

• What is new in cirrhosis? Frailty to palliative care
• Varices screening and prophylaxis
• Acute and chronic alcohol-associated liver disease
• NAFLD: Updates in diagnosis and management

Jennifer Lai, MD, MBA
Lorna M. Dove, MD, MPH
Jessica L. Mellinger, MD,MSc
Rohit Loomba, MD

• NBI, artificial intelligence, split prep – How else do I improve my ADR?
• Endoscopic recognition and management strategies for malignant colorectal polyps
• New concepts in the management of diverticulitis
• Genetic testing: When to refer and how to interpret results

Tonya Kaltenbach, MD, MAS
Douglas Rex, MD, AGAF
Anne F Peery, MD, MSCR, AGAF
Carol Burke, MD

• Choosing the right therapy for your patient: Ulcerative colitis
• Choosing the right therapy for your patient: Crohn’s disease
• Monitoring for success: Biomarkers, scopes and TDM
• Endoscopic surveillance and management of colorectal dysplasia in inflammatory bowel diseases

Millie Long, MD, AGAF
Siddharth Singh, MD
David Rubin, MD, AGAF
Fernando Velayos, MD, AGAF

• How to manage intractable constipation?
• Refractory GERD-a case-based approach
• Dilemmas in Barrett’s esophagus
• Decision making in EGJ outflow obstruction and achalasia
• Treatment strategies for EoE
• Complex Crohn’s disease:
  :
  1. Post-operative Crohn’s disease
  1. The Crohn’s patient refractory to FDA approved therapy

• Complex Ulcerative colitis:
  1. Severe UC: medical options
  2. Chronic refractory pouchitis
• Challenges in liver disease:
  1. Drug induced liver disease
  2. HCC
• Challenges in liver disease: Hepatitis:
  1. Hepatitis
  2. When to prophylaxAutoimmune hepatitis
• Evaluation and management of early complications
  after bariatric/metabolic surgery

• A rational approach to dyspepsia
• Dilemmas in celiac disease
• SIBO diagnosis and treatment dilemmas